Clinical trial
Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis…
NCT00384384 · Insel Gruppe AG, University Hospital Bern, Other · Completed
Key facts
| NCT number | NCT00384384 |
|---|---|
| Title | Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients |
| Official title | Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients |
| Lead sponsor | Insel Gruppe AG, University Hospital Bern, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | End Stage Renal Disease |
| Intervention type | Drug |
| Interventions | oral 18B Glycyrrhetinic acid versus placebo |
| Enrollment | 24 |
| Start date | Aug 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Oct 6, 2006 |
| Last update posted | Jan 13, 2011 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: